Genotype and phenotype analysis of patients with sporadic periodic paralysis

American Journal of the Medical Sciences

Volumn 343, Issue 4, 2012, Pages 281-285

  Sung, Chih Chien ^a   Cheng, Chih Jen ^a   Lo, Yi Fen ^b   Lin, Mei Shan ^c   Yang, Sung Sen ^a,b   Hsu, Yu Chuan ^a   Lin, Shih Hua ^a,b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Calcium channel; Hypokalemia; Paralysis; Sodium channel; Sporadic

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL ALPHA1 SUBUNIT; CARBOHYDRATE; GENOMIC DNA; LIOTHYRONINE; POTASSIUM ION; SODIUM CHANNEL; SODIUM CHANNEL ALPHA1 SUBUNIT; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARBOHYDRATE INTAKE; CHILD; COLD EXPOSURE; DNA ISOLATION; DNA SEQUENCE; EMOTIONAL STRESS; EXERCISE; FEMALE; FEVER; FREE THYROXINE INDEX; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN CELL; LEUKOCYTE; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; ONSET AGE; PERIODIC PARALYSIS; PHYSICAL ACTIVITY; POTASSIUM BLOOD LEVEL; SCHOOL CHILD; SEQUENCE ANALYSIS; SPORADIC PERIODIC PARALYSIS; THYROTROPIN BLOOD LEVEL; UPPER RESPIRATORY TRACT INFECTION;

EID: 84859108190     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31822b430c     Document Type: Article

References (35)

1. Stedwell RE, Allen KM, Binder LS. Hypokalemic paralyses: a review of the etiologies, pathophysiology, presentation and therapy. Am J Emerg Med 1992;10:143-6.
2. Lin SH, Lin YF, Halperin ML. Hypokalemia and paralysis. QJM 2001;94:133-9.
3. Lin SH, Halperin ML. Hypokalemia: a practical approach to diagnosis and its genetic basis. Curr Med Chem 2007;14:1551-65. (Pubitemid 46902215)
4. Lin SH, Lin YF, Chen DT, et al. Laboratory tests to determine the causes for hypokalemia and paralysis. Arch Intern Med 2004;164: 1561-6.
5. Lin SH. Thyrotoxic periodic paralysis. Mayo Clin Proc 2005;80:99-105.
6. Ko GTC, Chow CC, Yeung VTF, et al. Thyrotoxic periodic paralysis in a Chinese population. QJM 1996;89:463-8. (Pubitemid 26184332)
7. Phakdeekitcharoen B, Ruangraksa C, Radinahamed P. Hypokalaemia and paralysis in the Thai population. Nephrol Dial Transplant 2004;19:2013-8. (Pubitemid 39139631)
8. Ng WY, Lui KF, Thai AC, et al. Absence of ion channels CACN1AS and SCN4A mutations in thyrotoxic hypokalemic periodic paralysis. Thyroid 2004;14:187-90. (Pubitemid 38452190)
9. Wang W, Jiang L, Ye L, et al. Mutation screening in Chinese hypokalemic periodic paralysis patients. Mol Genet Metab 2006;87: 359-63.
10. Oker KP. Thyrotoxic periodic paralysis in the United States: report of 7 cases and review of the literature. Medicine 1992;71:109-20.
11. Chen KW, Hung TP, Lin TY. Periodic paralysis in Taiwan. Clinical study of 28 cases. Arch Neurol 1965;12:165-71.
12. Venance SL, Cannon SC, Fialho D, et al. The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain 2006;129:8-17. (Pubitemid 43063755)
13. Kung AW, Lau KS, Fong GC, et al. Association of novel single nucleotide polymorphisms in the calcium channel alpha 1 subunit gene (Ca(v) 1.1) and thyrotoxic periodic paralysis. J Clin Endocrinol Metab 2004;89:1340-5. (Pubitemid 38368434)
14. Fontaine B, Vale-Santos J, Jurkat-Rott K, et al. Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families. Nature Genet 1994;6:267-72. (Pubitemid 24188624)
15. Ptácek LJ, Tawil R, Griggs RC, et al. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 1994;77:863-8. (Pubitemid 24187684)
16. Elbaz A, Vale-Santos J, Jurkat-Rott K, et al. Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 Caucasian families. Am J Hum Genet 1995;56:374-80.
17. Lapie P, Lory P, Fontaine B. Hypokalemic periodic paralysis: an autosomal dominant muscle disorder caused by mutations in a voltage-gated calcium channel. Neuromuscul Disord 1997;7:234-40. (Pubitemid 27270290)
18. Jurkat-Rott K, Mitrovic N, Hang C, et al. Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci U S A 2000;97:9549-54. (Pubitemid 30650813)
19. Bulman DE, Scoggan KA, van Oene MD, et al. A novel sodium channel mutation in a family with hypokalemic periodic paralysis. Neurology 1999;10:1932-6.
20. Sternberg D, Maisonobe T, Jurkat-Rott K, et al. Hypokalemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. Brain 2001;124:1091-9. (Pubitemid 32510377)
21. Kim MK, Lee SH, Park MS, et al. Mutation screening in Korean hypokalemic periodic paralysis patients: a novel SCN4A Arg672Cys mutation. Neuromuscul Disord 2004;14:727-31.
22. Davies NP, Eunson LH, Samuel M, et al. Sodium channel gene mutations in hypokalemic periodic paralysis: an uncommon cause in the UK. Neurology 2001;9:1323-5. (Pubitemid 32947399)
23. Matthews E, Labrum R, Sweeney MG, et al. Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology 2009;72:1544-7.
24. Arhem P. Voltage sensing in ion channels: a 50-year-old mystery resolved? Lancet 2004;363:1221-3. (Pubitemid 38481850)
25. Ruff RL. Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology 2010;74:269.
26. Miller TM, Dias da Silva MR, Miller HA, et al. Correlating phenotype and genotype in the periodic paralyses. Neurology 2004; 63:1647-55. (Pubitemid 39507583)
27. Plaster NM, Tawil R, Tristani-Firouzi M, et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 2001;105:511-9. (Pubitemid 32520856)
28. Grosson CL, Esteban J, McKenna-Yasek D, et al. Hypokalemic periodic paralysis mutations: confirmation of mutation and analysis of founder effect. Neuromuscul Disord 1996;6:27-31. (Pubitemid 26016499)
29. Kim JB, Kim MH, Lee SJ, et al. The genotype and clinical phenotype of Korean patients with familial hypokalemic periodic paralysis. J Korean Med Sci 2007;22:946-51.
30. Lin SH, Hsu YD, Cheng NL, et al. Skeletal muscle dihydropyridine- sensitive calcium channel gene mutations in Chinese patients with hypokalemic periodic paralysis. Am J Med Sci 2005;329:66-70.
31. Minaker KL, Meneilly GS, Flier JS, et al. Insulin-mediated hypokalemia and paralysis in familial hypokalemic periodic paralysis. Am J Med 1988;84:1001-6.
32. + overload, major and reversible contributors to weakness by ion channel leaks. Proc Natl Acad Sci U S A 2009;106:4036-41.
33. Kim SH, Kim UK, Chae JJ, et al. Identification of mutations including de novo mutations in Korean patients with hypokalaemic periodic paralysis. Nephrol Dial Transplant 2001;16:939-44. (Pubitemid 32440365)
34. Kil TH, Kim JB. Severe respiratory phenotype caused by a de novo Arg528Gly mutation in the CACNA1S gene in a patient with hypokalemic periodic paralysis. Eur J Paediatr Neurol 2010;14:278-81.
35. Vadlamudi L, Dibbens LM, Lawrence KM, et al. Timing of de novo mutagenesis-a twin study of sodium-channel mutations. N Engl J Med 2010;363:1335-40.